abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
4-1BB
Back
Total number of drugs
221
Phase II and later clinical stages
7.2%
Involving companies
194
Main therapeutic areas
Neoplasms
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
PD-1 dependent 4-1BB agonist(Auburn University)PD-1 dependent 4-1BB agonist(Auburn University)Nanobody Bispecific antibodyNeoplasms4-1BB agonists PD-1 inhibitorsAuburn University College of Veterinary MedicineAuburn University College of Veterinary MedicinePreclinical--------PD-1 dependent 4-1BB agonist(Auburn University)--
detail  >
Pro-UrelumabPro-UrelumabMonoclonal antibodyNeoplasms4-1BB agonistsKaohsiung Medical UniversityKaohsiung Medical UniversityPreclinical--------Pro-Urelumab--
detail  >
7A5 (Eli Lilly & Co.)7A5 (Eli Lilly & Co.)Monoclonal antibodyNeoplasms4-1BB agonistsEli Lilly & Co.Eli Lilly & Co.Preclinical--------7A5 (Eli Lilly & Co.)--
detail  >
Anti-4-1bb/PD-1/VISTA mAbs (The University of Queensland)Anti-4-1bb/PD-1/VISTA mAbs (The University of Queensland)Trispecific antibodyNeoplasms4-1BB agonists PD-1 inhibitors VISTA inhibitorsThe University of QueenslandThe University of QueenslandPreclinical--------Anti-4-1bb/PD-1/VISTA mAbs (The University of Queensland)--
detail  >
TJ-MU4BTJ-MU4BBispecific antibodyNeoplasms4-1BB agonistsI-MAB Biopharma Co., Ltd.I-MAB Biopharma Co., Ltd.Preclinical--------TJ-MU4B--
detail  >
NBL-016NBL-016Bispecific antibodyNeoplasms Digestive System Disorders Endocrinology and Metabolic Disease4-1BB agonists CLDN18.2 modulatorsNovarock Biotherapeutics Ltd.Novarock Biotherapeutics Ltd.Preclinical--------NBL-016--
detail  >
M9657M9657Bispecific antibodyNeoplasms4-1BB agonists MSLN inhibitors PD-1 inhibitorsEMD Serono Research & Development Institute, Inc.EMD Serono Research & Development Institute, Inc.Preclinical--------M9657--
detail  >
APVO-603APVO-603Bispecific antibodyNeoplasms4-1BB agonists OX40 agonists ADCCAptevo Therapeutics, Inc.Aptevo Therapeutics, Inc.Preclinical--------APVO-603--
detail  >
4-1BB/Nectin-4 bispecific antibody (Twist Bioscience)4-1BB/Nectin-4 bispecific antibody (Twist Bioscience)Bispecific antibodyNeoplasms4-1BB agonists nectin-4 inhibitorsTwist Bioscience Corp.Twist Bioscience Corp.Preclinical--------4-1BB/Nectin-4 bispecific antibody (Twist Bioscience)--
detail  >
ABL112ABL112Bispecific antibodyNeoplasms4-1BB agonists TIGIT inhibitorsABL Bio, Inc.ABL Bio, Inc.Preclinical--------ABL112--
detail  >
Total 221 data
1
2
3
4
5
6
...
22
23